Mitsubishi Tanabe Pharma America logo
Join Us
  • About Us
  • Science
  • Community Resources
  • News and Media
  • Contact Us
Tanabe Pharma America
  • About Us
  • Science
  • Community Resources
  • News and Media
  • Contact Us
Join Us
  • Home
  • Contact Us

Questions?

For media relations inquiries, please contact
Media_TPA.US@mb.tanabe-pharma.com

Mitsubishi Tanabe Pharma America logo © 2026 Tanabe Pharma America, Inc. All rights reserved.
CP-TPA-US-0057 4/26
OUR COMPANY
  • About Us
  • Science
  • Community Resources
RESOURCES
  • Medical Inquiries
  • Our Compliance Program
NEWS AND MEDIA
  • News and Media
  • Media Assets
CONNECT WITH US
  • Facebook
  • Twitter
  • LinkedIn
  • Youtube
  • Global Site
  • Contact Us
  • Join Us
© 2026 Tanabe Pharma America, Inc. All rights reserved.
CP-TPA-US-0057 4/26

This information is intended for U.S. residents only
This information is intended for U.S. residents only
  • Terms of Use
  • Our Compliance Program
  • Privacy Policy
  • Health Data Privacy Policy
  • Our Policies
  • Sitemap
  • Cookie Preferences
You are leaving this website, hosted by Tanabe Pharma America, Inc.
This link will take you to a website to which our Privacy Policy and Terms of Use does not apply. Tanabe Pharma America, Inc. does not control the content of this third-party site.
Continue
Cancel

Registration of Clinical Trial Information and Disclosure of Results

a. Registration of our clinical trial information, and disclosure of results, to clinical trial registries

TPA will register and disclose information on publicly accessible clinical trial registries such as ClinicalTrials.gov regarding clinical trials that are being conducted or have been conducted.

b. Disclosure of clinical trial summary results

TPA will disclose the results from clinical trials in patients that form part of the submission package for products approved in the United States. Results will not be disclosed if TPA decides that disclosure may lead to identification of clinical trial participants. Results may not be disclosed under any of the following conditions:

  • A third party, such as a company involved in joint development, has not agreed to disclosure.
  • Disclosure may interfere with publication in medical journals.
  • Disclosure may interfere with the protection of intellectual property rights.